Canaccord Genuity Maintains Buy on First Tracks, Raises Price Target to $60
10/13/2026
Impact: 75
Healthcare
Canaccord Genuity analyst Edward Nash has maintained a Buy rating on First Tracks (NASDAQ: TRAX) and increased the price target from $50 to $60. This adjustment reflects the firm's positive outlook on the company's performance.
AI summary, not financial advice
Share: